Clinical Trial Update: LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the microcirculatory effects of landiolol in patients with septic shock, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• LANdiolol (landiolol hydrochloride)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic Shock | Phase 3 | Status: RECRUITING